PrimeRFP SCOUT · IDV / contract family

36F79721D0166IDV family

IDIQ 36F79721D0166 - 11 task orders is a federal IDV / contract family. SCOUT maps 11 distinctive task orders, with $16.8M obligated on the IDV rollup.

260-Network Contract Office 20 (36C260)
Awarding office
Through Sep 30, 2026
Period
$16.8M
IDV obligated
11
Task orders

Watch this IDV family

One email. No account. We ping you when orders or incumbents under this IDV move.

Family facts

IDV
Parent PIID36F79721D0166
Also listed as36F797-21-D-0166
Agency260-Network Contract Office 20 (36C260)
Awarding office260-Network Contract Office 20 (36C260)
Awarding agencyDepartment of Veterans Affairs (VA)
Period endSep 30, 2026
IDV obligated$16.8M
Child awards11
Bonuses end Sept 30

Want the durability read on 36F79721D0166? One Pursuit Analysis, $500, inside 48 business hours.

  • 48 business hours
  • $500
  • Credits toward the Pack
Buy one Pursuit Analysis — $500

Places of performance

States

MO, NC, OR

Distinctive task orders

11
75A50324F80012 — PERAMIVIR (RAPIVAB 200MG/20ML (10MG/ML INJ SOLN))
Biocryst Pharmaceuticals, Inc. · $13.9M · PoP Sep 29, 2025
36C26025F0070 — BULK ORLADEYO PHARMACEUTICAL
Biocryst Pharmaceuticals, Inc. · $395K · PoP Mar 11, 2026
36C26024F0270 — BULK ORDER ORLADEYO
Biocryst Pharmaceuticals, Inc. · $388K · PoP Mar 11, 2025
36C26025F0296 — BULK ORDER ORLADEYO FOR VETERAN CARE.
Biocryst Pharmaceuticals, Inc. · $382K · PoP Sep 8, 2026
36C26025F0024 — BEROTRALSTAT HCL 150MG CAP,ORAL (ORLADEYO).
Biocryst Pharmaceuticals, Inc. · $380K · PoP Sep 30, 2025
36C26024F0625 — BEROTRALSTAT HCL 150MG CAP,ORAL TRADE NAME: ORLADEYO 150MG CAP
Biocryst Pharmaceuticals, Inc. · $379K · PoP Sep 8, 2025
36C26022F0215 — BEROTRALSTAT HCL 150MG CAP,ORAL BULK, 72769-0101-01
Biocryst Pharmaceuticals, Inc. · $369K · PoP May 31, 2023
36C26026F0006 — PHARM - ORLADEYO
Biocryst Pharmaceuticals, Inc. · $360K · PoP Sep 30, 2026
36C26023F0144 — BEROTRALSTAT
Biocryst Pharmaceuticals, Inc. · $340K · PoP Jan 19, 2024
36C26024F0258 — ORLADEYO 150MG CAPS
Biocryst Pharmaceuticals, Inc. · $202K · PoP Oct 4, 2024
36C26026F0294 — ORLADEYO 150MG CAP
Biocryst Pharmaceuticals, Inc. · $151K · PoP Sep 30, 2026

Want the durability read on 36F79721D0166? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Buy one Pursuit Analysis — $500

Credits toward the Sprint Pack

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthly
Sources: USASpending, FPDS, SAM.gov · Public-record family rollup + SCOUT analysis; personalized scoring in SCOUT.
primerfp.com/intel/contract/36F79721D0166